Would, early, versus late hydroxocobalamin dose intensification treatment, prevent cognitive decline, macular degeneration and ocular disease, in 5 patients with early-onset cblC deficiency?

Emmanuel Scalais, Christine Geron, Charlotte Pierron, Sandra Cardillo, Vincent Schlesser, Frédéric Mataigne, Patricia Borde, Luc Regal

Onderzoeksoutput: Article › peer review

4 Citaten (Scopus)

Vingerafdruk

Duik in de onderzoeksthema's van 'Would, early, versus late hydroxocobalamin dose intensification treatment, prevent cognitive decline, macular degeneration and ocular disease, in 5 patients with early-onset cblC deficiency?'. Samen vormen ze een unieke vingerafdruk.

Medicine & Life Sciences